Patient Group | Group A | Group B | Group C | p-value | ||
A − B | A − C | B − C | ||||
Mean heart dose/Gy | 2.65 ± 0.98 (0.95 - 6.49) | 1.10 ± 0.29 (0.46 - 1.85) | 1.26 ± 0.25 (0.89 - 1.81) | <0.01 | <0.01 | 0.01 |
Median heart dose/Gy | 1.60 ± 0.43 (0.53 - 3.00) | 0.72 ± 0.19 (0.35 - 1.27) | 0.85 ± 0.24 (0.56 - 1.54) | <0.01 | <0.01 | 0.03 |
Heart V25/% | 1.27 ± 1.66 (0.00 - 8.82) | 0.01 ± 0.04 (0.00 - 0.25) | 0.01 ± 0.02 (0.00 - 0.06) | <0.01 | <0.01 | 0.09 |
Heart V25/cm3 | 7.10 ± 9.79 (0.00 - 52.00) | 0.07 ± 0.22 (0.00 - 1.47) | 0.03 ± 0.08 (0.00 - 0.30) | <0.01 | <0.01 | 0.11 |
Increased Risk of Ischemic heart disease/% | 19.6 ± 7.25 (7.03 - 40.03) | 8.1 ± 2.15 (3.40 - 13.69) | 9.3 ± 1.85 (6.59 - 13.39) | <0.01 | <0.01 | 0.01 |